<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:11:20Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13107" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13107</identifier><datestamp>2026-10-18T20:36:36Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Isotretinoin induced dysuria: A case report and review of literature about urological effects of isotretinoin; [İzotretinoine bağlı dizüri: Olgu sunumu ve isotretinoinin ürolojik yan etkilerinin değerlendirilmesi]</dc:title><dc:creator>Karaali, Müge Göre</dc:creator><dc:subject>dysuria</dc:subject><dc:subject>Isotretinoin</dc:subject><dc:subject>urology</dc:subject><dc:subject>acne vulgaris</dc:subject><dc:subject>adult</dc:subject><dc:subject>case report</dc:subject><dc:subject>clinical article</dc:subject><dc:subject>computer assisted tomography</dc:subject><dc:subject>drug withdrawal</dc:subject><dc:subject>human</dc:subject><dc:subject>male</dc:subject><dc:subject>Review</dc:subject><dc:subject>urinalysis</dc:subject><dc:subject>urine culture</dc:subject><dc:subject>young adult</dc:subject><dc:description>Isotretinoin is often used in the treatment of severe acne. However, many adverse reactions were reported, including mucocutaneous, metabolic, neurological and psychiatric, ophthalmologic, hematologic side effects and teratogenicity. The mucocutaneous are the most common side effects and often develop in a dose-dependent manner. I present a case of a 20-year-old male with the unusual non-specific dysuria only and review the literature on the urological effects of isotretinoin. © 2021 Istanbul Assoc. of Dermatology and Venerology. All rights reserved.</dc:description><dc:publisher>Istanbul Assoc. of Dermatology and Venerology</dc:publisher><dc:date>2021</dc:date><dc:type>Review Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/13107</dc:identifier><dc:identifier>https://doi.org/10.4274/turkderm.galenos.2021.81073</dc:identifier><dc:identifier>2717-6398</dc:identifier><dc:language>en</dc:language><dc:relation>Turkderm Turkish Archives of Dermatology and Venereology</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/review</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/13107</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>